nodes	percent_of_prediction	percent_of_DWPC	metapath
Trandolapril—CES1—larynx—thyroid cancer	0.0715	0.423	CbGeAlD
Trandolapril—CES1—neck—thyroid cancer	0.019	0.112	CbGeAlD
Trandolapril—ACE—neck—thyroid cancer	0.0126	0.0746	CbGeAlD
Trandolapril—CES1—thyroid gland—thyroid cancer	0.00902	0.0534	CbGeAlD
Trandolapril—SLC15A2—saliva-secreting gland—thyroid cancer	0.00858	0.0507	CbGeAlD
Trandolapril—CES1—head—thyroid cancer	0.008	0.0473	CbGeAlD
Trandolapril—SLC15A2—trachea—thyroid cancer	0.00662	0.0391	CbGeAlD
Trandolapril—Mitiglinide—PPARG—thyroid cancer	0.00639	0.663	CrCbGaD
Trandolapril—ACE—thyroid gland—thyroid cancer	0.006	0.0355	CbGeAlD
Trandolapril—CES1—lymph node—thyroid cancer	0.0056	0.0331	CbGeAlD
Trandolapril—ACE—head—thyroid cancer	0.00532	0.0315	CbGeAlD
Trandolapril—SLC15A2—thyroid gland—thyroid cancer	0.00523	0.031	CbGeAlD
Trandolapril—SLC15A2—head—thyroid cancer	0.00464	0.0275	CbGeAlD
Trandolapril—ACE—lymph node—thyroid cancer	0.00373	0.0221	CbGeAlD
Trandolapril—Nateglinide—PPARG—thyroid cancer	0.00325	0.338	CrCbGaD
Trandolapril—SLC15A2—lymph node—thyroid cancer	0.00325	0.0192	CbGeAlD
Trandolapril—Photosensitivity—Epirubicin—thyroid cancer	0.00141	0.00171	CcSEcCtD
Trandolapril—Constipation—Sorafenib—thyroid cancer	0.0014	0.00171	CcSEcCtD
Trandolapril—Eczema—Epirubicin—thyroid cancer	0.00137	0.00167	CcSEcCtD
Trandolapril—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00134	0.00163	CcSEcCtD
Trandolapril—Renal failure acute—Epirubicin—thyroid cancer	0.00134	0.00163	CcSEcCtD
Trandolapril—Hot flush—Epirubicin—thyroid cancer	0.00132	0.00161	CcSEcCtD
Trandolapril—Blood alkaline phosphatase increased—Doxorubicin—thyroid cancer	0.00131	0.0016	CcSEcCtD
Trandolapril—Menopausal symptoms—Epirubicin—thyroid cancer	0.00131	0.00159	CcSEcCtD
Trandolapril—Urticaria—Sorafenib—thyroid cancer	0.0013	0.00159	CcSEcCtD
Trandolapril—Photosensitivity—Doxorubicin—thyroid cancer	0.0013	0.00158	CcSEcCtD
Trandolapril—Body temperature increased—Sorafenib—thyroid cancer	0.0013	0.00158	CcSEcCtD
Trandolapril—Abdominal pain—Sorafenib—thyroid cancer	0.0013	0.00158	CcSEcCtD
Trandolapril—Eczema—Doxorubicin—thyroid cancer	0.00127	0.00155	CcSEcCtD
Trandolapril—Cardiac failure—Epirubicin—thyroid cancer	0.00127	0.00154	CcSEcCtD
Trandolapril—Cerebrovascular accident—Epirubicin—thyroid cancer	0.00126	0.00153	CcSEcCtD
Trandolapril—Hyponatraemia—Epirubicin—thyroid cancer	0.00124	0.00151	CcSEcCtD
Trandolapril—Renal failure acute—Doxorubicin—thyroid cancer	0.00124	0.00151	CcSEcCtD
Trandolapril—Osteoarthritis—Epirubicin—thyroid cancer	0.00123	0.0015	CcSEcCtD
Trandolapril—Pain in extremity—Epirubicin—thyroid cancer	0.00123	0.0015	CcSEcCtD
Trandolapril—Hot flush—Doxorubicin—thyroid cancer	0.00122	0.00149	CcSEcCtD
Trandolapril—Migraine—Epirubicin—thyroid cancer	0.00122	0.00148	CcSEcCtD
Trandolapril—Menopausal symptoms—Doxorubicin—thyroid cancer	0.00121	0.00147	CcSEcCtD
Trandolapril—Hypersensitivity—Sorafenib—thyroid cancer	0.00121	0.00147	CcSEcCtD
Trandolapril—Asthenia—Sorafenib—thyroid cancer	0.00118	0.00143	CcSEcCtD
Trandolapril—Cardiac arrest—Epirubicin—thyroid cancer	0.00117	0.00143	CcSEcCtD
Trandolapril—Cardiac failure—Doxorubicin—thyroid cancer	0.00117	0.00143	CcSEcCtD
Trandolapril—Cerebrovascular accident—Doxorubicin—thyroid cancer	0.00117	0.00142	CcSEcCtD
Trandolapril—Pruritus—Sorafenib—thyroid cancer	0.00116	0.00141	CcSEcCtD
Trandolapril—Blood creatinine increased—Epirubicin—thyroid cancer	0.00116	0.00141	CcSEcCtD
Trandolapril—Hyponatraemia—Doxorubicin—thyroid cancer	0.00115	0.0014	CcSEcCtD
Trandolapril—Pain in extremity—Doxorubicin—thyroid cancer	0.00114	0.00139	CcSEcCtD
Trandolapril—Osteoarthritis—Doxorubicin—thyroid cancer	0.00114	0.00139	CcSEcCtD
Trandolapril—Liver function test abnormal—Epirubicin—thyroid cancer	0.00114	0.00139	CcSEcCtD
Trandolapril—Dry skin—Epirubicin—thyroid cancer	0.00113	0.00138	CcSEcCtD
Trandolapril—Migraine—Doxorubicin—thyroid cancer	0.00112	0.00137	CcSEcCtD
Trandolapril—Diarrhoea—Sorafenib—thyroid cancer	0.00112	0.00137	CcSEcCtD
Trandolapril—Breast disorder—Epirubicin—thyroid cancer	0.00112	0.00136	CcSEcCtD
Trandolapril—Toxic epidermal necrolysis—Epirubicin—thyroid cancer	0.00111	0.00135	CcSEcCtD
Trandolapril—Gastritis—Epirubicin—thyroid cancer	0.00109	0.00133	CcSEcCtD
Trandolapril—Alanine aminotransferase increased—Epirubicin—thyroid cancer	0.00109	0.00133	CcSEcCtD
Trandolapril—Cardiac arrest—Doxorubicin—thyroid cancer	0.00109	0.00132	CcSEcCtD
Trandolapril—Dizziness—Sorafenib—thyroid cancer	0.00109	0.00132	CcSEcCtD
Trandolapril—Abdominal distension—Epirubicin—thyroid cancer	0.00107	0.00131	CcSEcCtD
Trandolapril—Blood creatinine increased—Doxorubicin—thyroid cancer	0.00107	0.0013	CcSEcCtD
Trandolapril—Eosinophilia—Epirubicin—thyroid cancer	0.00106	0.00129	CcSEcCtD
Trandolapril—Liver function test abnormal—Doxorubicin—thyroid cancer	0.00105	0.00128	CcSEcCtD
Trandolapril—Dry skin—Doxorubicin—thyroid cancer	0.00105	0.00128	CcSEcCtD
Trandolapril—Pancreatitis—Epirubicin—thyroid cancer	0.00105	0.00127	CcSEcCtD
Trandolapril—Vomiting—Sorafenib—thyroid cancer	0.00104	0.00127	CcSEcCtD
Trandolapril—Angina pectoris—Epirubicin—thyroid cancer	0.00104	0.00127	CcSEcCtD
Trandolapril—Rash—Sorafenib—thyroid cancer	0.00104	0.00126	CcSEcCtD
Trandolapril—Dermatitis—Sorafenib—thyroid cancer	0.00103	0.00126	CcSEcCtD
Trandolapril—Breast disorder—Doxorubicin—thyroid cancer	0.00103	0.00126	CcSEcCtD
Trandolapril—Toxic epidermal necrolysis—Doxorubicin—thyroid cancer	0.00103	0.00125	CcSEcCtD
Trandolapril—Headache—Sorafenib—thyroid cancer	0.00103	0.00125	CcSEcCtD
Trandolapril—Bronchitis—Epirubicin—thyroid cancer	0.00103	0.00125	CcSEcCtD
Trandolapril—Pancytopenia—Epirubicin—thyroid cancer	0.00101	0.00123	CcSEcCtD
Trandolapril—Gastritis—Doxorubicin—thyroid cancer	0.00101	0.00123	CcSEcCtD
Trandolapril—Alanine aminotransferase increased—Doxorubicin—thyroid cancer	0.00101	0.00123	CcSEcCtD
Trandolapril—Neutropenia—Epirubicin—thyroid cancer	0.000998	0.00121	CcSEcCtD
Trandolapril—Abdominal distension—Doxorubicin—thyroid cancer	0.000994	0.00121	CcSEcCtD
Trandolapril—Upper respiratory tract infection—Epirubicin—thyroid cancer	0.000992	0.00121	CcSEcCtD
Trandolapril—Pollakiuria—Epirubicin—thyroid cancer	0.000986	0.0012	CcSEcCtD
Trandolapril—Eosinophilia—Doxorubicin—thyroid cancer	0.000978	0.00119	CcSEcCtD
Trandolapril—Nausea—Sorafenib—thyroid cancer	0.000975	0.00119	CcSEcCtD
Trandolapril—Photosensitivity reaction—Epirubicin—thyroid cancer	0.000974	0.00119	CcSEcCtD
Trandolapril—Pancreatitis—Doxorubicin—thyroid cancer	0.000968	0.00118	CcSEcCtD
Trandolapril—Hyperglycaemia—Epirubicin—thyroid cancer	0.000963	0.00117	CcSEcCtD
Trandolapril—Angina pectoris—Doxorubicin—thyroid cancer	0.000962	0.00117	CcSEcCtD
Trandolapril—Infestation NOS—Epirubicin—thyroid cancer	0.000952	0.00116	CcSEcCtD
Trandolapril—Infestation—Epirubicin—thyroid cancer	0.000952	0.00116	CcSEcCtD
Trandolapril—Drowsiness—Epirubicin—thyroid cancer	0.000952	0.00116	CcSEcCtD
Trandolapril—Bronchitis—Doxorubicin—thyroid cancer	0.00095	0.00116	CcSEcCtD
Trandolapril—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	0.000943	0.00115	CcSEcCtD
Trandolapril—Pancytopenia—Doxorubicin—thyroid cancer	0.000938	0.00114	CcSEcCtD
Trandolapril—Renal failure—Epirubicin—thyroid cancer	0.000935	0.00114	CcSEcCtD
Trandolapril—Urinary tract infection—Epirubicin—thyroid cancer	0.000925	0.00113	CcSEcCtD
Trandolapril—Neutropenia—Doxorubicin—thyroid cancer	0.000923	0.00112	CcSEcCtD
Trandolapril—Upper respiratory tract infection—Doxorubicin—thyroid cancer	0.000918	0.00112	CcSEcCtD
Trandolapril—Sweating—Epirubicin—thyroid cancer	0.000912	0.00111	CcSEcCtD
Trandolapril—Pollakiuria—Doxorubicin—thyroid cancer	0.000912	0.00111	CcSEcCtD
Trandolapril—Photosensitivity reaction—Doxorubicin—thyroid cancer	0.000901	0.0011	CcSEcCtD
Trandolapril—Hepatobiliary disease—Epirubicin—thyroid cancer	0.0009	0.0011	CcSEcCtD
Trandolapril—Epistaxis—Epirubicin—thyroid cancer	0.000897	0.00109	CcSEcCtD
Trandolapril—Hyperglycaemia—Doxorubicin—thyroid cancer	0.000891	0.00108	CcSEcCtD
Trandolapril—Agranulocytosis—Epirubicin—thyroid cancer	0.000888	0.00108	CcSEcCtD
Trandolapril—Drowsiness—Doxorubicin—thyroid cancer	0.00088	0.00107	CcSEcCtD
Trandolapril—Infestation—Doxorubicin—thyroid cancer	0.00088	0.00107	CcSEcCtD
Trandolapril—Infestation NOS—Doxorubicin—thyroid cancer	0.00088	0.00107	CcSEcCtD
Trandolapril—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	0.000873	0.00106	CcSEcCtD
Trandolapril—Bradycardia—Epirubicin—thyroid cancer	0.00087	0.00106	CcSEcCtD
Trandolapril—Renal failure—Doxorubicin—thyroid cancer	0.000865	0.00105	CcSEcCtD
Trandolapril—Rhinitis—Epirubicin—thyroid cancer	0.000856	0.00104	CcSEcCtD
Trandolapril—Urinary tract infection—Doxorubicin—thyroid cancer	0.000856	0.00104	CcSEcCtD
Trandolapril—Hepatitis—Epirubicin—thyroid cancer	0.000854	0.00104	CcSEcCtD
Trandolapril—Pharyngitis—Epirubicin—thyroid cancer	0.000848	0.00103	CcSEcCtD
Trandolapril—Sweating—Doxorubicin—thyroid cancer	0.000844	0.00103	CcSEcCtD
Trandolapril—Urinary tract disorder—Epirubicin—thyroid cancer	0.000844	0.00103	CcSEcCtD
Trandolapril—Oedema peripheral—Epirubicin—thyroid cancer	0.000841	0.00102	CcSEcCtD
Trandolapril—Connective tissue disorder—Epirubicin—thyroid cancer	0.000839	0.00102	CcSEcCtD
Trandolapril—Urethral disorder—Epirubicin—thyroid cancer	0.000837	0.00102	CcSEcCtD
Trandolapril—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.000833	0.00101	CcSEcCtD
Trandolapril—Epistaxis—Doxorubicin—thyroid cancer	0.00083	0.00101	CcSEcCtD
Trandolapril—Visual impairment—Epirubicin—thyroid cancer	0.000823	0.001	CcSEcCtD
Trandolapril—Agranulocytosis—Doxorubicin—thyroid cancer	0.000822	0.001	CcSEcCtD
Trandolapril—Erythema multiforme—Epirubicin—thyroid cancer	0.000808	0.000983	CcSEcCtD
Trandolapril—Bradycardia—Doxorubicin—thyroid cancer	0.000805	0.00098	CcSEcCtD
Trandolapril—Eye disorder—Epirubicin—thyroid cancer	0.000798	0.000972	CcSEcCtD
Trandolapril—Tinnitus—Epirubicin—thyroid cancer	0.000796	0.00097	CcSEcCtD
Trandolapril—Flushing—Epirubicin—thyroid cancer	0.000793	0.000965	CcSEcCtD
Trandolapril—Cardiac disorder—Epirubicin—thyroid cancer	0.000793	0.000965	CcSEcCtD
Trandolapril—Rhinitis—Doxorubicin—thyroid cancer	0.000792	0.000965	CcSEcCtD
Trandolapril—Hepatitis—Doxorubicin—thyroid cancer	0.00079	0.000962	CcSEcCtD
Trandolapril—Pharyngitis—Doxorubicin—thyroid cancer	0.000784	0.000955	CcSEcCtD
Trandolapril—Urinary tract disorder—Doxorubicin—thyroid cancer	0.000781	0.00095	CcSEcCtD
Trandolapril—Oedema peripheral—Doxorubicin—thyroid cancer	0.000779	0.000948	CcSEcCtD
Trandolapril—Connective tissue disorder—Doxorubicin—thyroid cancer	0.000777	0.000946	CcSEcCtD
Trandolapril—Angiopathy—Epirubicin—thyroid cancer	0.000775	0.000944	CcSEcCtD
Trandolapril—Urethral disorder—Doxorubicin—thyroid cancer	0.000775	0.000943	CcSEcCtD
Trandolapril—Immune system disorder—Epirubicin—thyroid cancer	0.000772	0.000939	CcSEcCtD
Trandolapril—Mediastinal disorder—Epirubicin—thyroid cancer	0.00077	0.000937	CcSEcCtD
Trandolapril—Arrhythmia—Epirubicin—thyroid cancer	0.000763	0.000929	CcSEcCtD
Trandolapril—Visual impairment—Doxorubicin—thyroid cancer	0.000762	0.000927	CcSEcCtD
Trandolapril—Alopecia—Epirubicin—thyroid cancer	0.000755	0.000919	CcSEcCtD
Trandolapril—Mental disorder—Epirubicin—thyroid cancer	0.000748	0.000911	CcSEcCtD
Trandolapril—Erythema multiforme—Doxorubicin—thyroid cancer	0.000747	0.00091	CcSEcCtD
Trandolapril—Malnutrition—Epirubicin—thyroid cancer	0.000744	0.000905	CcSEcCtD
Trandolapril—Eye disorder—Doxorubicin—thyroid cancer	0.000739	0.000899	CcSEcCtD
Trandolapril—Tinnitus—Doxorubicin—thyroid cancer	0.000737	0.000897	CcSEcCtD
Trandolapril—Flushing—Doxorubicin—thyroid cancer	0.000734	0.000893	CcSEcCtD
Trandolapril—Cardiac disorder—Doxorubicin—thyroid cancer	0.000734	0.000893	CcSEcCtD
Trandolapril—Flatulence—Epirubicin—thyroid cancer	0.000733	0.000892	CcSEcCtD
Trandolapril—Dysgeusia—Epirubicin—thyroid cancer	0.000728	0.000887	CcSEcCtD
Trandolapril—Back pain—Epirubicin—thyroid cancer	0.000719	0.000876	CcSEcCtD
Trandolapril—Angiopathy—Doxorubicin—thyroid cancer	0.000717	0.000873	CcSEcCtD
Trandolapril—Muscle spasms—Epirubicin—thyroid cancer	0.000715	0.00087	CcSEcCtD
Trandolapril—Immune system disorder—Doxorubicin—thyroid cancer	0.000714	0.000869	CcSEcCtD
Trandolapril—Mediastinal disorder—Doxorubicin—thyroid cancer	0.000712	0.000867	CcSEcCtD
Trandolapril—Arrhythmia—Doxorubicin—thyroid cancer	0.000706	0.00086	CcSEcCtD
Trandolapril—Alopecia—Doxorubicin—thyroid cancer	0.000698	0.00085	CcSEcCtD
Trandolapril—Mental disorder—Doxorubicin—thyroid cancer	0.000692	0.000843	CcSEcCtD
Trandolapril—Ill-defined disorder—Epirubicin—thyroid cancer	0.00069	0.00084	CcSEcCtD
Trandolapril—Malnutrition—Doxorubicin—thyroid cancer	0.000688	0.000838	CcSEcCtD
Trandolapril—Anaemia—Epirubicin—thyroid cancer	0.000687	0.000837	CcSEcCtD
Trandolapril—Agitation—Epirubicin—thyroid cancer	0.000683	0.000832	CcSEcCtD
Trandolapril—Flatulence—Doxorubicin—thyroid cancer	0.000678	0.000825	CcSEcCtD
Trandolapril—Dysgeusia—Doxorubicin—thyroid cancer	0.000674	0.00082	CcSEcCtD
Trandolapril—Malaise—Epirubicin—thyroid cancer	0.000671	0.000816	CcSEcCtD
Trandolapril—Vertigo—Epirubicin—thyroid cancer	0.000668	0.000813	CcSEcCtD
Trandolapril—Syncope—Epirubicin—thyroid cancer	0.000667	0.000812	CcSEcCtD
Trandolapril—Leukopenia—Epirubicin—thyroid cancer	0.000666	0.00081	CcSEcCtD
Trandolapril—Back pain—Doxorubicin—thyroid cancer	0.000666	0.00081	CcSEcCtD
Trandolapril—Muscle spasms—Doxorubicin—thyroid cancer	0.000661	0.000805	CcSEcCtD
Trandolapril—Palpitations—Epirubicin—thyroid cancer	0.000657	0.0008	CcSEcCtD
Trandolapril—Loss of consciousness—Epirubicin—thyroid cancer	0.000654	0.000796	CcSEcCtD
Trandolapril—Cough—Epirubicin—thyroid cancer	0.000649	0.00079	CcSEcCtD
Trandolapril—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000638	0.000777	CcSEcCtD
Trandolapril—Anaemia—Doxorubicin—thyroid cancer	0.000636	0.000774	CcSEcCtD
Trandolapril—Arthralgia—Epirubicin—thyroid cancer	0.000633	0.000771	CcSEcCtD
Trandolapril—Chest pain—Epirubicin—thyroid cancer	0.000633	0.000771	CcSEcCtD
Trandolapril—Myalgia—Epirubicin—thyroid cancer	0.000633	0.000771	CcSEcCtD
Trandolapril—Agitation—Doxorubicin—thyroid cancer	0.000632	0.00077	CcSEcCtD
Trandolapril—Anxiety—Epirubicin—thyroid cancer	0.000631	0.000768	CcSEcCtD
Trandolapril—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000629	0.000765	CcSEcCtD
Trandolapril—Discomfort—Epirubicin—thyroid cancer	0.000625	0.000762	CcSEcCtD
Trandolapril—Malaise—Doxorubicin—thyroid cancer	0.00062	0.000755	CcSEcCtD
Trandolapril—Dry mouth—Epirubicin—thyroid cancer	0.000619	0.000754	CcSEcCtD
Trandolapril—Vertigo—Doxorubicin—thyroid cancer	0.000618	0.000753	CcSEcCtD
Trandolapril—Syncope—Doxorubicin—thyroid cancer	0.000617	0.000751	CcSEcCtD
Trandolapril—Leukopenia—Doxorubicin—thyroid cancer	0.000616	0.00075	CcSEcCtD
Trandolapril—Palpitations—Doxorubicin—thyroid cancer	0.000608	0.00074	CcSEcCtD
Trandolapril—Oedema—Epirubicin—thyroid cancer	0.000607	0.000739	CcSEcCtD
Trandolapril—Loss of consciousness—Doxorubicin—thyroid cancer	0.000605	0.000736	CcSEcCtD
Trandolapril—Infection—Epirubicin—thyroid cancer	0.000603	0.000734	CcSEcCtD
Trandolapril—Cough—Doxorubicin—thyroid cancer	0.0006	0.000731	CcSEcCtD
Trandolapril—Shock—Epirubicin—thyroid cancer	0.000597	0.000727	CcSEcCtD
Trandolapril—Nervous system disorder—Epirubicin—thyroid cancer	0.000595	0.000725	CcSEcCtD
Trandolapril—Thrombocytopenia—Epirubicin—thyroid cancer	0.000594	0.000723	CcSEcCtD
Trandolapril—Tachycardia—Epirubicin—thyroid cancer	0.000592	0.000721	CcSEcCtD
Trandolapril—Skin disorder—Epirubicin—thyroid cancer	0.000589	0.000718	CcSEcCtD
Trandolapril—Hyperhidrosis—Epirubicin—thyroid cancer	0.000587	0.000714	CcSEcCtD
Trandolapril—Chest pain—Doxorubicin—thyroid cancer	0.000586	0.000713	CcSEcCtD
Trandolapril—Myalgia—Doxorubicin—thyroid cancer	0.000586	0.000713	CcSEcCtD
Trandolapril—Arthralgia—Doxorubicin—thyroid cancer	0.000586	0.000713	CcSEcCtD
Trandolapril—Anxiety—Doxorubicin—thyroid cancer	0.000584	0.000711	CcSEcCtD
Trandolapril—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000582	0.000708	CcSEcCtD
Trandolapril—Discomfort—Doxorubicin—thyroid cancer	0.000579	0.000705	CcSEcCtD
Trandolapril—Anorexia—Epirubicin—thyroid cancer	0.000578	0.000704	CcSEcCtD
Trandolapril—Dry mouth—Doxorubicin—thyroid cancer	0.000573	0.000697	CcSEcCtD
Trandolapril—Hypotension—Epirubicin—thyroid cancer	0.000567	0.00069	CcSEcCtD
Trandolapril—Oedema—Doxorubicin—thyroid cancer	0.000562	0.000684	CcSEcCtD
Trandolapril—Infection—Doxorubicin—thyroid cancer	0.000558	0.000679	CcSEcCtD
Trandolapril—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000553	0.000673	CcSEcCtD
Trandolapril—Shock—Doxorubicin—thyroid cancer	0.000552	0.000673	CcSEcCtD
Trandolapril—Nervous system disorder—Doxorubicin—thyroid cancer	0.000551	0.00067	CcSEcCtD
Trandolapril—Thrombocytopenia—Doxorubicin—thyroid cancer	0.00055	0.000669	CcSEcCtD
Trandolapril—Insomnia—Epirubicin—thyroid cancer	0.000549	0.000668	CcSEcCtD
Trandolapril—Tachycardia—Doxorubicin—thyroid cancer	0.000548	0.000667	CcSEcCtD
Trandolapril—Skin disorder—Doxorubicin—thyroid cancer	0.000545	0.000664	CcSEcCtD
Trandolapril—Paraesthesia—Epirubicin—thyroid cancer	0.000545	0.000663	CcSEcCtD
Trandolapril—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000543	0.000661	CcSEcCtD
Trandolapril—Dyspnoea—Epirubicin—thyroid cancer	0.000541	0.000659	CcSEcCtD
Trandolapril—Somnolence—Epirubicin—thyroid cancer	0.000539	0.000657	CcSEcCtD
Trandolapril—Anorexia—Doxorubicin—thyroid cancer	0.000535	0.000652	CcSEcCtD
Trandolapril—Dyspepsia—Epirubicin—thyroid cancer	0.000534	0.00065	CcSEcCtD
Trandolapril—Decreased appetite—Epirubicin—thyroid cancer	0.000528	0.000642	CcSEcCtD
Trandolapril—Hypotension—Doxorubicin—thyroid cancer	0.000525	0.000639	CcSEcCtD
Trandolapril—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000524	0.000638	CcSEcCtD
Trandolapril—Fatigue—Epirubicin—thyroid cancer	0.000523	0.000637	CcSEcCtD
Trandolapril—Constipation—Epirubicin—thyroid cancer	0.000519	0.000632	CcSEcCtD
Trandolapril—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000512	0.000623	CcSEcCtD
Trandolapril—Insomnia—Doxorubicin—thyroid cancer	0.000508	0.000618	CcSEcCtD
Trandolapril—Paraesthesia—Doxorubicin—thyroid cancer	0.000504	0.000614	CcSEcCtD
Trandolapril—Dyspnoea—Doxorubicin—thyroid cancer	0.000501	0.00061	CcSEcCtD
Trandolapril—Feeling abnormal—Epirubicin—thyroid cancer	0.0005	0.000609	CcSEcCtD
Trandolapril—Somnolence—Doxorubicin—thyroid cancer	0.000499	0.000608	CcSEcCtD
Trandolapril—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000496	0.000604	CcSEcCtD
Trandolapril—Dyspepsia—Doxorubicin—thyroid cancer	0.000494	0.000602	CcSEcCtD
Trandolapril—Decreased appetite—Doxorubicin—thyroid cancer	0.000488	0.000594	CcSEcCtD
Trandolapril—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000485	0.00059	CcSEcCtD
Trandolapril—Fatigue—Doxorubicin—thyroid cancer	0.000484	0.000589	CcSEcCtD
Trandolapril—Urticaria—Epirubicin—thyroid cancer	0.000482	0.000587	CcSEcCtD
Trandolapril—Constipation—Doxorubicin—thyroid cancer	0.00048	0.000585	CcSEcCtD
Trandolapril—Abdominal pain—Epirubicin—thyroid cancer	0.00048	0.000584	CcSEcCtD
Trandolapril—Body temperature increased—Epirubicin—thyroid cancer	0.00048	0.000584	CcSEcCtD
Trandolapril—Feeling abnormal—Doxorubicin—thyroid cancer	0.000463	0.000563	CcSEcCtD
Trandolapril—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000459	0.000559	CcSEcCtD
Trandolapril—Hypersensitivity—Epirubicin—thyroid cancer	0.000447	0.000544	CcSEcCtD
Trandolapril—Urticaria—Doxorubicin—thyroid cancer	0.000446	0.000543	CcSEcCtD
Trandolapril—Abdominal pain—Doxorubicin—thyroid cancer	0.000444	0.00054	CcSEcCtD
Trandolapril—Body temperature increased—Doxorubicin—thyroid cancer	0.000444	0.00054	CcSEcCtD
Trandolapril—Asthenia—Epirubicin—thyroid cancer	0.000435	0.00053	CcSEcCtD
Trandolapril—Pruritus—Epirubicin—thyroid cancer	0.000429	0.000523	CcSEcCtD
Trandolapril—Diarrhoea—Epirubicin—thyroid cancer	0.000415	0.000506	CcSEcCtD
Trandolapril—Hypersensitivity—Doxorubicin—thyroid cancer	0.000414	0.000504	CcSEcCtD
Trandolapril—Asthenia—Doxorubicin—thyroid cancer	0.000403	0.000491	CcSEcCtD
Trandolapril—Dizziness—Epirubicin—thyroid cancer	0.000401	0.000489	CcSEcCtD
Trandolapril—Pruritus—Doxorubicin—thyroid cancer	0.000397	0.000484	CcSEcCtD
Trandolapril—Vomiting—Epirubicin—thyroid cancer	0.000386	0.00047	CcSEcCtD
Trandolapril—Diarrhoea—Doxorubicin—thyroid cancer	0.000384	0.000468	CcSEcCtD
Trandolapril—Rash—Epirubicin—thyroid cancer	0.000383	0.000466	CcSEcCtD
Trandolapril—Dermatitis—Epirubicin—thyroid cancer	0.000382	0.000465	CcSEcCtD
Trandolapril—Headache—Epirubicin—thyroid cancer	0.00038	0.000463	CcSEcCtD
Trandolapril—Dizziness—Doxorubicin—thyroid cancer	0.000371	0.000452	CcSEcCtD
Trandolapril—Nausea—Epirubicin—thyroid cancer	0.00036	0.000439	CcSEcCtD
Trandolapril—Vomiting—Doxorubicin—thyroid cancer	0.000357	0.000435	CcSEcCtD
Trandolapril—Rash—Doxorubicin—thyroid cancer	0.000354	0.000431	CcSEcCtD
Trandolapril—Dermatitis—Doxorubicin—thyroid cancer	0.000354	0.000431	CcSEcCtD
Trandolapril—Headache—Doxorubicin—thyroid cancer	0.000352	0.000428	CcSEcCtD
Trandolapril—Nausea—Doxorubicin—thyroid cancer	0.000334	0.000406	CcSEcCtD
